Inventor · disambiguated record
Sung Soo Jun
Also filed as: JUN SUNG SOO
17 granted patents·21 pending applications·66 citations·filing 2006–2018
92Inventor score
Files withKIM SUNG WUK17HANALL BIOPHARMA CO LTD8HANALL PHARMACEUTICAL CO LTD4IMMUNOMET THERAPEUTICS INC3CHEON HYAE GYEONG1
Top patents by PatentIndex Score
38 records- 0190US9133110B2Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredientKIM SUNG WUK·Filed 2011·Granted Sep 15, 2015·14 cites·4 claims
- 0287US8058312B2N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the sameKIM SUNG WUK·Filed 2008·Granted Nov 15, 2011·10 cites·17 claims
- 0385US9464042B2Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredientIMMUNOMET THERAPEUTICS INC·Filed 2015·Granted Oct 11, 2016·4 cites·3 claims
- 0484US9416098B2Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredientKIM SUNG WUK·Filed 2011·Granted Aug 16, 2016·6 cites·8 claims
- 0584US8648111B2N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredientsKIM SUNG WUK·Filed 2009·Granted Feb 11, 2014·9 cites·12 claims
- 0684US8076377B2N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the sameKIM SUNG WUK·Filed 2008·Granted Dec 13, 2011·10 cites·4 claims
- 0781US8642647B2N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing sameKIM SUNG WUK·Filed 2009·Granted Feb 4, 2014·6 cites·15 claims
- 0875US8394845B2Method of using combination preparation comprising angiotensin-II-receptor blocker and HMG-CoA reductase inhibitorKIM SUNG WUK·Filed 2011·Granted Mar 12, 2013·4 cites·10 claims
- 0973US9993446B2Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredientIMMUNOMET THERAPEUTICS INC·Filed 2016·Granted Jun 12, 2018·1 cites·7 claims
- 1069US8541474B2N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the sameKIM SUNG WUK·Filed 2011·Granted Sep 24, 2013·1 cites·3 claims
- 1166US9068019B2Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2010·Granted Jun 30, 2015·1 cites·8 claims
- 1263US10376480B2Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredientIMMUNOMET THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·0 cites·6 claims
- 1361US2011123612A1Pharmaceutical preparation containing non-dihydropyridine calcium channel blocker and angiotensin-2 receptor blockerKIM SUNG WUK·Filed 2009·Application pending·0 cites
- 1460US2011052683A1Pharmaceutical preparation for treating cardiovascular diseaseHANALL BIOPHARMA CO LTD·Filed 2009·Application pending·0 cites
- 1560US2011111021A1Pharmaceutical preparationHANALL BIOPHARMA CO LTD·Filed 2009·Application pending·0 cites
- 1660US2011038931A1Composite preparationHANALL BIOPHARMA CO LTD·Filed 2009·Application pending·0 cites
- 1757US2008241240A1Combined pharmaceutical formulation with controlled-release comprising dihydropyridine calcium channel blockers and hmg-coa reductase inhibitorsHANALL PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 1855US2010047341A1Combined preparation for the treatment of cardiovascular diseases based on chronotherapy theoryHANALL PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
- 1952US9655916B2Compositions for external application, containing adenosylcobalamin for improvement of skin diseasesKOREA RES INST CHEMICAL TECH·Filed 2015·Granted May 23, 2017·0 cites·13 claims
- 2052US2008050432A1Combined Pharmaceutical Formulation with Controlled-Release Comprising Dihydropyridine Calcium Channel Blockers and HMG-COA Reductase InhibitorsJUN SUNG SOO·Filed 2007·Application pending·0 cites
- 2151US2013084329A1Compositions for external application, containing adenosylcobalamin for improvement of skin diseasesKOREA RES INST CHEM TECH·Filed 2012·Application pending·0 cites
- 2249US2014235558A1Pharmaceutical composition having activity of anticancerHANALL BIOPHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2349US2011111022A1Pharmaceutical formulationHANALL BIOPHARMA CO LTD·Filed 2009·Application pending·0 cites
- 2448US2012015032A1Combination preparation comprising inhibitor of hmg-coa reductase and aspirin and method for manufacturing the sameKIM SUNG WUK·Filed 2008·Application pending·0 cites
- 2548US2011117194A1Pharmaceutical formulation containing angiotensin-ii receptor blockerHANALL BIOPHARMA CO LTD·Filed 2009·Application pending·0 cites
- 2647US2010272797A1Pharmaceutical Composition for Treating Hepatitis C Virus Infection Comprising HMG-COA Reductase Inhibitor and Bile AcidHANALL PHARMACEUTICAL CO LTD·Filed 2008·Application pending·0 cites
- 2746US8642083B2Controlled release complex composition comprising angiotensin-II-receptor blockers and HMG-CoA reductase inhibitorsKIM SUNG WUK·Filed 2007·Granted Feb 4, 2014·0 cites·42 claims
- 2844US2013071471A1Pharmaceutical composition for treating atopic dermatitisHANALL BIOPHARMA CO LTD·Filed 2012·Application pending·0 cites
- 2944US2009137523A1Compositions for External Application, Containing Adenosyl Cobalamin for Improvement of Skin DiseasesSHIN BYUNG CHEOL·Filed 2006·Application pending·0 cites
- 3044US2014235559A1Anti-cancer pharmaceutical compositionKIM SUNG-WUK·Filed 2011·Application pending·0 cites
- 3143US2010143470A1Controlled release pharmaceutical composition containing thiazides and angiotensin-ii-receptor blockersHANALL PHARMACEUTICAL CO LTD·Filed 2007·Application pending·0 cites
- 3242US8722674B21,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the sameCHEON HYAE GYEONG·Filed 2008·Granted May 13, 2014·0 cites·5 claims
- 3341US8895500B2Modified human tumor necrosis factor receptor-I polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2011·Granted Nov 25, 2014·0 cites·18 claims
- 3441US2011294733A1Modified human thrombopoietin polypeptide fragment and manufacturing method thereofKIM SUNG WUK·Filed 2010·Application pending·0 cites
- 3539US8754037B2Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing sameKIM SUNG WUK·Filed 2011·Granted Jun 17, 2014·0 cites·24 claims
- 3636US2011135714A1Compositions for external application, containing adenosyl cobalamin for improvement of skin diseasesKOREAN RES INST OF CHEMICAL TECHNOLOGY·Filed 2011·Application pending·0 cites
- 3735US2011212175A1Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitorHANALL BIOPHARMA CO LTD·Filed 2011·Application pending·0 cites
- 3833US2012135952A1Butyric acid salt of n,n-dimethyl imidocarbon imidic diamide, method of preparing same, and pharmaceutical compositions and combinations containing sameKIM SUNG WUK·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sung Soo Jun files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →